<DOC>
	<DOCNO>NCT01232504</DOCNO>
	<brief_summary>We conduct prospective , multicenter , open-label randomize trial compare antifungal effect Recombinant Human Granulocyte-macrophage Stimulating Factor ( rhGM-CSF ) , Recombinant Human Granulocyte Stimulating Factor ( rhG-CSF ) combination rhGM-CSF rhG-CSF neutropenic patient undergo allogeneic stem cell transplantation .</brief_summary>
	<brief_title>Antifugal Effect Recombinant Human Granulocyte-macrophage Stimulating Factor ( rhGM-CSF ) Patients Post Allo-HSCT</brief_title>
	<detailed_description>From Sept 2009 Dec 2012 , recruit consecutive patient hematological disease undergo allogeneic stem cell transplantation 5 institution China . Recipients age 14 60 year old eligible . Eligible patient randomize receive daily subcutaneous 5-7μg/kg/d GM-CSF ( Molgramostim , TOPLEUCON® ; Xiamen Amoytop Biotech Co. , Ltd. , China ) ( GM-CSF group ) , 5-7μg/kg/d G-CSF ( G-CSF group ) , combination 2-3μg/kg/d GM-CSF 2-3μg/kg/d G-CSF ( G-CSF+GM-CSF group ) . Administration CSFs start day 5 post-transplant continued recovery neutropenia ( absolute neutrophil count [ ANC ] &gt; 1.5×10 ( 9 ) /L 2 consecutive day ) . If absolute neutrophil count ( ANC ) decrease &lt; 1.5×10 ( 9 ) /L within 5 day withdrawal CSFs , CSF would resume absolute neutrophil count ( ANC ) reach 1.5×10 ( 9 ) /L . All patient receive antimicrobial prophylaxis oral levofloxacin 500 mg daily antifungal prophylaxis oral fluconazole 200 mg daily .</detailed_description>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Age 14~60 year old Allogenic hematological stem cell transplantation ( HSCT ) patient . Cardiac ejection factor ≥ normal upper limit , Aspartate aminotransferase and/or Alanine aminotransferase &lt; 2 upper limit normal , and/or total bilirubin &lt; 2.5 upper limit normal , creatinine &lt; upper limit normal . Informed consent . Evidence proven , probable possible fungal infection time enrollment . Patients receive antifungal treatment proven SFI transplantation . A history hypersensitivity GCSF GMCSF .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Allo-HSCT</keyword>
	<keyword>rhGM-CSF</keyword>
	<keyword>Systemic fungal infection ( SFI )</keyword>
</DOC>